MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
Abbott Laboratories Retained Earnings 2011-2026 | ABT
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.8 B | 47.3 B | 37.6 B | 35.3 B | 31.5 B | 27.6 B | 25.8 B | 24.6 B | 24 B | 25.6 B | 25.8 B | 22.9 B | 22 B | 24.2 B | 20.9 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 49.8 B | 20.9 B | 29.6 B |
Quarterly Retained Earnings Abbott Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.5 B | 47.7 B | 39.1 B | 38.4 B | 38 B | 36.9 B | 36.4 B | 35.9 B | 35.3 B | 35.1 B | - | 33.3 B | 31.5 B | 30.4 B | 29.1 B | 28.7 B | 27.6 B | 27.6 B | 27.6 B | 27.6 B | 25.8 B | 25.8 B | 25.8 B | 25.8 B | 24.6 B | 24.6 B | 24.6 B | 24.6 B | 24 B | 24 B | 24 B | 24 B | 25.6 B | 25.6 B | 25.6 B | 25.6 B | 25.8 B | 25.8 B | 25.8 B | 25.8 B | 22.9 B | 22.9 B | 22.9 B | 22.9 B | 22 B | 22 B | 22 B | 22 B | 24.2 B | 24.2 B | 24.2 B | 24.2 B | 20.9 B | 20.9 B | 20.9 B | 20.9 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 48.5 B | 20.9 B | 27.6 B |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.21 | -0.43 % | $ 3.45 M |  USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 12.93 | -0.92 % | $ 1.94 B | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 10.53 | 0.77 % | $ 1.42 B | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 9.69 | -13.17 % | $ 274 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.66 | -2.96 % | $ 35.9 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.82 | -5.91 % | $ 142 M |  France |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 8.32 | -0.48 % | $ 597 M |  Israel |
 |
Establishment Labs Holdings
ESTA
|
-496 M | $ 65.54 | 0.81 % | $ 1.94 B |  Costa-rica |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.06 | -4.92 % | $ 859 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 70.78 | -0.59 % | $ 105 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 37.4 | 0.16 % | $ 1.16 B | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
InMode Ltd.
INMD
|
969 M | $ 13.57 | -0.62 % | $ 877 M | Israel |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.33 | - | $ 21.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 16.8 | -2.38 % | $ 394 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.44 | -0.05 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.49 | -2.57 % | $ 340 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.42 B | $ 269.13 | -0.13 % | $ 7.59 B | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.07 | -4.61 % | $ 1.26 M | USA |
 |
AxoGen
AXGN
|
-307 M | $ 31.04 | -5.22 % | $ 1.43 B | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 172.05 | -2.31 % | $ 12.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 8.93 | -1.92 % | $ 688 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 34.17 | 1.27 % | $ 5.09 K | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
-89.1 M | $ 3.74 | -0.13 % | $ 154 M | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
-519 M | $ 0.39 | -0.46 % | $ 40.1 M | USA |
 |
IRadimed Corporation
IRMD
|
64.2 M | $ 101.34 | -1.42 % | $ 1.29 B | USA |